COLLECTION AND BANKING OF BIOLOGICAL SAMPLES AND COLLECTION OF CLINICAL DATA FROM PERSONS WITH BLOOD DISORDERS

Size: px
Start display at page:

Download "COLLECTION AND BANKING OF BIOLOGICAL SAMPLES AND COLLECTION OF CLINICAL DATA FROM PERSONS WITH BLOOD DISORDERS"

Transcription

1 Childhood Cancer Blood Research Program BioBanking Initiative Information and Consent Form Blood Disorders COLLECTION AND BANKING OF BIOLOGICAL SAMPLES AND COLLECTION OF CLINICAL DATA FROM PERSONS WITH BLOOD DISORDERS Principal Investigator: Dr Suzanne Vercauteren UBC Department of Pathology and Laboratory Medicine Children s & Women s Health Centre of BC Physicians Division of Hematology/Oncology/BMT, Children s & Women s Health Centre of BC Dr. Jeffrey Davis, MD, FRCPC Dr. Chris Fryer, MD, FRCPC Dr. Juliette Hukin, MD, FRCPC Dr. Sheila Pritchard, MD, FRCPC Dr. David Dix, MD, FRCPC Dr. Rebecca Deyell, MD, FRCPC Dr. Rod Rassekh, MD, FRCPC Dr. Paul Rogers, MD, FRCPC Dr. Kirk Schultz, MD, FRCPC Dr. Caron Strahlendorf, MD,FRCPC Dr. John Wu, MD, FRCPC Dr. Jacob Rozmus, MD, FRCPC Dr Jessica Halparin, MD, FRCPC Research Scientists, Childhood Cancer and Blood Research, Child & Family Research Institute Dr. Catherine Pallen, PhD Dr. Sandra Dunn, PhD Dr. James Lim, PhD Dr. Chris Maxwell, PhD Dr. Gregor Reid, PhD BioBank Coordinator: Tamsin Tarling, MSc. (604) ext 6423 Emergency Telephone Number: (604) hours/day, 7 days a week Toll Free Number (BC only): For both numbers listed above, inform the Operator that you wish to speak to the Hem/Onc/BMT Physician On-Call Introduction Doctors at Children s and Women s Health Centre of BC (C&W) and scientists at the Child and Family Research Institute (CFRI) have created a research group called the Childhood Cancer and Blood Research group (CCBR). This group wants to create a bank (or library) of samples for use in research to better understand how to correct diseases of the blood. The CCBR BioBank is governed by the ethical standards overseen by the UBC / C&W Research Ethics Board (REB) as well as the Executive Committee for Management and Operations (ECMO) of the CCBR Biobank. These two groups ensure that all children donating samples to the Biobank are protected as research participants by the applicable standards that govern the operation of BioBanks. It is important that you understand that if you sign this Page 1 of 9

2 consent form, you are consenting to the banking of your samples for future research projects, which as of now, are undefined. You/your child are being invited to take part in this initiative because you/your child has or is suspected to have a blood disorder. This consent form is to help you/your child decide if you/your child want to participate in the CCBR BioBank initiative. The Principal Investigator and BioBank Coordinator will be happy to answer all your questions. From this point forward when we use you and your in this consent form, we mean you or your child. Your participation is voluntary Your participation is entirely voluntary. Before deciding, it is important for you to understand what the BioBank involves. This consent form will tell you about the banking of samples, why the banking is being done, and what will happen to these samples, in addition to the possible benefits, risks and discomforts to you. If you decide to participate, you will be asked to sign this form. If you do decide to participate, you are still free to withdraw at any time and without giving any reasons. If you do not wish to participate, you do not have to provide any reason for your decision not to participate nor will you lose the benefit of medical care to which you are entitled or are presently receiving. Please take time to read the following information carefully and to discuss it with your family, friends and doctor before making a decision. Background Every day the body produces billions of new white blood cells, red blood cells and other blood cells. All of these blood cells are produced in the bone marrow which is located inside most of the bones in the body. The blood cells then move into the blood stream where they fight infection, provide energy and help clot the blood. Occasionally, something goes wrong with the growth and behavior of these blood cells and a blood disease develops. While many blood diseases can be treated, much work still needs to be done to find safer and more effective cures. Who can donate to the CCBR BioBank? All children treated for a blood disorder are eligible to contribute samples to the CCBR BioBank. What will happen if I decide to donate to the CCBR BioBank? Sample Donation We are inviting you to donate small samples of blood or bone marrow (up to 5 mls, 1 teaspoon). We would also like to collect any left over blood, DNA stem cells, Cerebrospinal Fluid (CSF) or leukapheresis product (white blood cells) for storage in the CCBR BioBank and for use in future research projects. All of these samples will be collected during a clinical procedure necessary for the diagnosis or treatment of your (suspected) blood disorder. No additional procedures will be required. 1. Collection of Bone Marrow You may need to have checked bone marrow procedure to see whether the bone marrow is involved. If so, you may need follow up bone marrow procedures. throughout your treatment. If you agree to participate in the CCBR BioBank we request that a doctor take an extra amount of your bone marrow (about 2-5 millilitres, or ½ - 1 teaspoon) when a sample is required for clinical reasons. Page 2 of 9

3 2. Collection of Blood Samples, CSF and Leukapheresis products If, after routine clinical procedures there is any blood, CSF or leukapheresis products left over, we ask your permission to store these left over samples in the CCBR BioBank,. 3. Collection of left over DNA from Cytogenetic analysis In order to make your diagnosis, the clinical cytogenetics laboratory may need to isolate DNA in your bone marrow/blood. We would like to ask your permission to store any left over DNA in the BioBank after these tests have been completed. Even if you agree to donate this left over DNA, the clinical cytogenetics laboratory will keep a small amount for the unlikely need for re testing or additional testing on a sample representing your bone marrow/blood at this point in your diagnosis. However, there is always a chance that the amount of DNA deemed reasonable for re testing or additional testing may not be sufficient. 4. Collection of left over stem cells If you are donating peripheral blood stem cells or bone marrow harvested stem cells for a stem cell transplant (either for yourself or for a family member) and the transplant does not take place as planned, or there are cells left over after transplant, those samples will be kept frozen in storage for 10 years. Following the 10 year period you are given the option to have the samples stored in an alternate storage facility, for example Life Bank, donate them to the CCBR BioBank or have them destroyed. In the event that an abundant stem cell collection occurs and there are more cells than clinically required, a small volume may be given to the CCBR BioBank provided you have agreed. This will be at the discretion of your doctor and the director of the apheresis program (the program in which stem cells are collected). 6. Use of old biospecimens If you had a previous diagnosis of a malignancy in the past there may be old (archived) biospecimens l stored in the Department of Pathology and Laboratory Medicine. Often these are no longer required for clinical purposes; would you be willing to donate these old (archived) specimens to the CCBR BioBank? To be absolutely clear that we understand what you have decided upon, please check the boxes on the following page to tell us your wishes: Page 3 of 9

4 Yes No Collection of Bone Marrow I agree to have up to 2-5 milliliters (or ½-1 teaspoon) of bone marrow taken at the same time as a sample is required for clinical purposes for the CCBR BioBank. Collection of left over biospecimens I agree to donate the following left over biospecimens to the CCBR BioBank. Yes No Blood Yes No CSF Yes No Leukopheresis Products Yes No DNA Yes No Stem Cells Yes No N/A Use of old biospecimens I agree to donate old (archived) biospecimens that have previously been stored and are no longer required for clinical purposes. Collection of Data To better understand what scientists may see when doing their research on your samples in relation to your disease and its treatment we will review your medical chart at various time points throughout the period of time you participate in the CCBR BioBank, and collect your health related information. Information that will be collected may include all or some of the following: 1) Medical history from the time of diagnosis and throughout treatment and follow up. 2) Medications you have received for your disorder. 3) Results from laboratory and medical tests. 4) Demographic information, such as date of birth, gender, and ethnic background. 5) Information about your treatment. Both your samples and your medical information will be assigned a unique BioBank number so that none of your samples or health information will have your name on it. No information that discloses your identity will be released. In addition to the above information, we would like your permission to be able to contact you in the future about possible other research which may be unrelated to the scope of research carried out by the CCBR BioBank. Please indicate in the box below if you are willing to be contacted in the future, this contact may be by telephone. As stated above only the BioBank Coordinator will have access to your personal or contact information and thus it would be his/her responsibility to contact you. I am willing to be contacted in the future regarding other research I am not willing to be contacted in the future regarding other research Page 4 of 9

5 What will my samples be used for? At this time the specific research project your samples will be used for is undetermined. Scientists will have to obtain ethical approval as well as submit an extensive proposal to obtain samples from the CCBR BioBank. Samples will be used primarily for research into blood and cancer related disorders, however if you are willing to donate your samples to be used in any type of research, please indicate this as your wish by initialing the statement below. I am willing to donate my samples to be used in any type of medical research I am only willing to donate my samples to be used for cancer or blood research Scientists worldwide will be able to apply for your samples. If you wish for your samples to be used by international researchers, please indicate this as your wish by initially the statement below. Please note that legislation may differ between countries. The CCBR BioBank will NOT release personal identifiers such as your name and date of birth but as always in scientific research there is an inherent risk of loss of confidentiality. I consent to having my samples used by international researchers. I consent to only having my samples used by Canadian researchers How long will samples be collected and stored? If you decide to donate samples to the CCBR BioBank and sign this consent form, samples will be collected for the duration of the time you receive treatment and follow-up care for your disease and you will NOT be asked to consent again. You will be informed, at the time of your procedure, that a sample is being collected for the CCBR BioBank. Samples will be stored indefinitely in the CCBR BioBank. The CCBR BioBank will do their best to re-contact you on your 18 th birthday to discuss your continued participation in the BioBank. Where will the samples be stored? Samples will be stored in a secure freezer in an access limited laboratory of the CFRI. Only CCBR BioBank staff will have access to this freezer. What are the possible harms and side effects associated with donating to the CCBR BioBank? Since only a small sample of biological material will be collected for the BioBank and no additional procedures are being requested, it is unlikely that there will be any harm to you. It should be noted that the amount of biological sample taken from you has been carefully considered. Under no circumstances will additional procedures occur just for the purpose of obtaining samples for the BioBank. Because certain demographics, specifically your date of birth, diagnosis and sex are being collected, there is a risk of your identity being revealed but all efforts will be made to minimize that as a possibility. The CCBR BioBank function is to store your samples and match them with reputable investigators who have ethical approval for their work. NO genetic analysis of your samples will be carried out by the CCBR BioBank. However, genetic studies may be carried out with your samples once they have been released to an investigator. The intention of the CCBR BioBank is Page 5 of 9

6 to maintain confidentiality at all times. However, there is a very small risk that information gained from genetic research could eventually be linked to you and possibly other members of your biological family. What are the benefits of donating to the CCBR BioBank? You will not directly benefit from donating samples to the CCBR BioBank. We hope that any information learned from the research conducted can be used in the future to benefit other people with blood disorders. Research done with your samples may help to develop new treatments. How much of my time will donating to the CCBR BioBank take? Aside from the time it takes you to read this consent form and ask questions regarding the banking of your samples, participation in this research will not require any time on your part. What if I choose not to donate? If you do not wish to donate to the BioBank you will continue to receive the accepted standard of care. Your doctor will do the usual studies and tests that children with blood disorders normally get. There is no difference in treatment between those who wish to donate and those who do not wish to donate. What happens if I decide to withdraw my consent to participate? Participation in the CCBR BioBank is entirely voluntary. You may withdraw from donating to the CCBR BioBank at any time and request that the samples that have been collected be destroyed. If you decide to withdraw, there will be no penalty or loss of benefits to which you are otherwise entitled, and your future medical care will not be affected. In order to withdraw from the BioBank you may contact your physician or you can notify the BioBank Coordinator, Tamsin Tarling directly at , extension Upon notice of withdrawal, a form will be completed by the CCBR BioBank coordinator. Please note that any information that has been gathered from your medical chart(s) and your samples will be destroyed but that it will not be possible to remove information derived from your samples prior to notification of withdrawal. In addition, it may not be possible to destroy samples and medical information that has already been distributed to investigators. What happens to my samples if the bank has to close? You will be informed by letter if the bank closes. All samples as well as paper and electronic documentation will be destroyed. What will donating to the BioBank cost me? You will not incur any expenses as a result of donation of samples to the CCBR BioBank. You will not be paid for donating any samples for research purposes. You will not be paid for donating samples for research purposes. You will not financially benefit from discoveries or commercial products developed from samples you have donated. The CCBR BioBank will provide samples to researchers on a cost recovery basis; this is to ensure that the CCBR BioBank remains sustainable. NO profit will be made. What happens if something goes wrong? If you become injured or unexpectedly ill as a consequence of donating to the BioBank, your medical condition will be evaluated and medical care will be provided by one of the investigators or you will be referred for appropriate treatment. Page 6 of 9

7 Signing this consent form in no way limits your legal rights against the sponsor, investigators, or anyone else involved in the CCBR BioBanking initiative Will donating to the CCBR BioBank be kept confidential? Your confidentiality will be respected to the extent permitted by applicable laws and regulations and your medical and study records will not be publicly available. Your identity will not be used in any reports that arise from any studies in which your samples are used. All samples will be de-identified and given a unique code number. The BioBank Coordinator is the guardian of the BioBank medical information portion of the database. Only he/she will have access to your personal identifying information. The BioBank Coordinator may give de-identified information from your records to a researcher only under conditions where the clinical information is necessary for the specific research project. All information associated with the CCBR BioBank will be kept in a password protected database and in locked filing cabinets, only accessible by the BioBank coordinator. Reports and results of research done with your samples will not be given to you or your doctor. These reports will not be put in your medical records. The research using your samples will not affect your care. Research records and medical records identifying you may be inspected in the presence of the Investigator or his or her designate by representatives of any funding agencies, and the UBC Research Ethics Boards or applicable BioBanking agencies for the purpose of monitoring the BioBank. However, no records which identify you by name or initials will be allowed to leave the Investigators' offices. Your rights to privacy are protected by the Freedom of Information and Protection of Privacy Act of British Columbia. This act lays down safeguards respecting your privacy and gives you the right of access to your information. You will also have the right to correct any errors in this information if necessary. Further details about this act are available upon request. Please note that the same legislation will not necessarily apply in different countries. The CCBR BioBank may release your samples to a foreign investigator (with your permission, see page 3) but as stated previously your name and date of birth will not be released and the research project for which your sample will be used MUST have prior ethical approval. Who do I contact if I have questions about donating to the CCBR BioBank? If you have any questions or would like to have more information about donating to the BioBank you can contact Dr Suzanne Vercauteren, BioBank Chair and Principal Investigator at or the BioBank Coordinator, Tamsin Tarling at (604) extension Who do I contact if I have questions or concerns about my rights in relation to donating to the CCBR BioBank? If you have any concerns about your rights in relation to donating to the CCBR BioBank, please contact the Research Subject Information Line at the UBC Office of Research Services by at RSIL@ors.ubc.ca or by phone at (604) or the toll free line at CCBR BioBank Initiative - Information and Consent Form Blood Disorders By signing this consent form I am agreeing to the collection of clinical information and donation of samples to the CCBR BioBank for the entire time period that I receive treatment and/or Page 7 of 9

8 follow-up at C&W Health Centre of BC. This time period may last several years depending on my disease. I understand that donating to the CCBR BioBank is entirely voluntary. I may refuse to have samples and clinical information collected from me at any time without having to explain my decision. Checking in the boxes beside each of these statements indicates I have read and understood them. I have read and understood the subject information and consent form. I understand that I am consenting to the banking of my samples for future research projects, which are as of now, are undefined. I understand that the use of my samples will be for research purposes only. I understand that should any commercial products be developed from subsequent research, the CCBR will assert all rights arising from use of my samples. I understand that I will not be paid should this research result in a commercial product. I have had sufficient time to consider the information provided and to ask for advice if necessary. I have had the opportunity to ask questions and have had satisfactory responses to my questions. I understand that during the course of my treatment, I will not be re-consented every time I donate a sample to the BioBank I understand that all of the information collected will be kept confidential and will only be used for scientific objectives. I understand that donation to the CCBR BioBank is voluntary and that I am completely free to refuse to participate or withdraw from participating at any time without changing the quality of care that I receive. If I chose to withdraw my samples will be destroyed, if that is my choice. I understand that I am not waiving any of my legal rights as a result of signing this consent form. I understand that there is no guarantee that donating samples to the CCBR BioBank will provide any benefits to me. I understand that information will be collected from my medical chart(s) for research purposes. I have read this form and I freely consent to donating samples to the CCBR BioBank based on the information provided. I have been told that I will receive a dated and signed copy of this form. Name of Parent/Guardian (Please Print) Signature of Parent/Guardian Date I have asked the participant if they have any questions regarding the information in this consent form. The participant has understood the nature of my answers to any of their questions regarding the information contained in this consent form. Name of designate obtaining consent Signature of designate obtaining consent Date Name of translator (if applicable) Signature of translator (if applicable) Date Copy to: Participant Clinic chart BioBank Coordinator Page 8 of 9

9 Childhood Cancer Blood Research Program BioBanking Initiative Decline to Consent Form I have explained the Childhood Cancer and Blood BioBanking initiative to Insert Participant Name (Please Print) and his/her questions have been answered He/she has declined to participate in the Childhood Cancer and Blood Research BioBank initiative on dd/mm/yy In indicating the above, this participant s decision will be entered into the BioBank database so that he/she will not be approached again for participation in the Childhood Cancer and Blood Research BioBanking initiative. Name of Physician or designate (Please Print) Signature of Physician or designate Date Copy to: Participant Clinic chart BioBank Coordinator Page 9 of 9

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY Study Title: Assessment of Biochemical Pathways and Biomarker Discovery in Autism Spectrum Disorder This is a research

More information

About this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form

About this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form Protocol Title: Gene Sequence Variants in Fibroid Biology Principal Investigator: Cynthia C. Morton, Ph.D. Site Principal Investigator: Cynthia C. Morton, Ph.D. Description of About this consent form Please

More information

Northwestern University Department of Urology CONSENT FORM AND AUTHORIZATION FOR RESEARCH

Northwestern University Department of Urology CONSENT FORM AND AUTHORIZATION FOR RESEARCH Northwestern University Department of Urology CONSENT FORM AND AUTHORIZATION FOR RESEARCH Project Title: Genetics of Prostate Cancer Principal Investigator or Faculty Advisor: William J. Catalona, M.D.

More information

HREC/17/RCHM/334 RCH HREC 37278A. ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank.

HREC/17/RCHM/334 RCH HREC 37278A. ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank. HREC Project Number: Research Project Title: Principal Researchers: HREC/17/RCHM/334 RCH HREC 37278A ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank. Associate Professor Justine

More information

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY Epileptic Encephalopathies: Clinical and Genetic Predictors of Outcomes and Therapeutic Insights This is a research study.

More information

Title of Research Study: Discovery and Validation of Biomarkers for Lichen Sclerosus

Title of Research Study: Discovery and Validation of Biomarkers for Lichen Sclerosus Page 1 of 8 Informed Consent for Participation in a Research Study Title of Research Study: Discovery and Validation of Biomarkers for Lichen Sclerosus Investigator Contact Information: Principal Investigator:

More information

DF/HCC Principal Research Doctor / Institution: Irene Ghobrial, MD / DFCI

DF/HCC Principal Research Doctor / Institution: Irene Ghobrial, MD / DFCI Protocol Title: Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progression and Clinical Outcome DF/HCC Principal Research Doctor / Institution: Irene

More information

RESEARCH CONSENT FORM

RESEARCH CONSENT FORM Use Plate or Print: DO NOT PLACE IN MEDICAL RECORD Protocol Title: Genetic studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs) and their associated anomalies Principal Investigator:

More information

Vanderbilt University Institutional Review Board Informed Consent Document for Research. Name of participant: Age:

Vanderbilt University Institutional Review Board Informed Consent Document for Research. Name of participant: Age: This informed consent applies to: Adults Name of participant: Age: The following is given to you to tell you about this research study. Please read this form with care and ask any questions you may have

More information

UNIVERSITY HOSPITALS CASE MEDICAL CENTER CONSENT FOR INVESTIGATIONAL STUDIES (v )

UNIVERSITY HOSPITALS CASE MEDICAL CENTER CONSENT FOR INVESTIGATIONAL STUDIES (v ) UNIVERSITY HOSPITALS CASE MEDICAL CENTER CONSENT FOR INVESTIGATIONAL STUDIES (v. 11.2012) Project Title: The Impact of Achilles Tightness on Lower Etremity Injuries in Adolescent Athletes Principal Investigator:

More information

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO BE IN RESEARCH

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO BE IN RESEARCH UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO BE IN RESEARCH CC#:125519: Radiologically Guided Biopsies Of Metastatic Castration Resistant Prostate Cancer to Identify Adaptive Mechanisms Of Resistance

More information

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014 Approval : September 10, 2013 Expiration : September 10, 2014 DESCRIPTION: The goal of Assisted Reproductive Technology (ART) is to help infertile couples to become pregnant. During treatment, some cellular

More information

VERBAL CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND HIPPA AUTHORIZATION

VERBAL CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND HIPPA AUTHORIZATION VERBAL CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND HIPPA AUTHORIZATION Study Title: Cytokine Production and Lymphoproliferation With and Without Co-inhibitory Signaling Blockade: An Assessment of Functional

More information

CONSENT FORM. The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith

CONSENT FORM. The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith CONSENT FORM The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith Queen Elizabeth Hospital Queen Elizabeth Hospital 60 Riverside Drive 60

More information

We are inviting you to participate in a research study/project that has two components.

We are inviting you to participate in a research study/project that has two components. Dear TEACCH Client: One of the missions of the TEACCH Autism Program is to support research on the treatment and cause of autism and related disorders. Therefore, we are enclosing information on research

More information

Donor Registration and Consent for HLA Typing

Donor Registration and Consent for HLA Typing Place NMDP Bar Code label here Jackie (left), donated to save the life of Paizley (right) Randy (left), donated to save the life of Luke (right) Tobias (left), donated to save the life of Betsy (right)

More information

UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT INFORMED CONSENT AND HIPAA AUTHORIZATION FORM

UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT INFORMED CONSENT AND HIPAA AUTHORIZATION FORM UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT INFORMED CONSENT AND HIPAA AUTHORIZATION FORM Protocol Title: Principal Investigator: 24 hr. Emergency Contact: Evaluating the HIV-1 Reservoir: BEAT HIV Delaney

More information

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM CONSENT TO PARTICIPATE IN A LONG TERM FOLLOW UP TO A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM CONSENT TO PARTICIPATE IN A LONG TERM FOLLOW UP TO A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM CONSENT TO PARTICIPATE IN A LONG TERM FOLLOW UP TO A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION Protocol No. VRX496-USA-11-001-LTFU: Long-term Follow-up

More information

We are inviting you to participate in a research study/project that has two components.

We are inviting you to participate in a research study/project that has two components. Dear TEACCH Client: One of the missions of the TEACCH Autism Program is to support research on the treatment and cause of autism and related disorders. Therefore, we are enclosing information on research

More information

SUBJECT INFORMATION AND CONSENT FORM

SUBJECT INFORMATION AND CONSENT FORM Title of Study: Department of Anesthesiology British Columbia s Children Hospital 4480 Oak Street Vancouver V6H 3V4 Tel 604 875 2711 Fax 604 875 3221 SUBJECT INFORMATION AND CONSENT FORM Mobile Health:

More information

IRB Approval From: 3/8/2010 To: 10/28/2010

IRB Approval From: 3/8/2010 To: 10/28/2010 UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 (Version 3.0, 16 FEB 2010) IRB Approval From:

More information

INFORMATION BROCHURE - ALLOCATE

INFORMATION BROCHURE - ALLOCATE INFORMATION BROCHURE - ALLOCATE AustraLian Ovarian Cancer Assortment Trial Principal Investigator: Prof Michael Quinn, Royal Women s Hospital This Participant Information Sheet and Consent Form is 7 pages

More information

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections Study INFORMATION SHEET FOR PATIENT 18th August Version 3.

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections Study INFORMATION SHEET FOR PATIENT 18th August Version 3. INFORMATION SHEET FOR PATIENT We are undertaking a research study involving people with severe [*** insert as appropriate respiratory infection (H5N1 or H7N9 or Mers-CoV), or viral haemorrhagic fever ***],

More information

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM White Blood Cell Collection by Leukapheresis in HIV-infected Individuals On Chemotherapy and Controls Not on Chemotherapy: A Study of HIV Reservoir Eradication CONSENT TO PARTICIPATE IN A RESEARCH STUDY

More information

CONSENT TO GENETIC TESTING THROUGH A RESEARCH STUDY

CONSENT TO GENETIC TESTING THROUGH A RESEARCH STUDY CONSENT TO GENETIC TESTING THROUGH A RESEARCH STUDY Title Principal Investigator Genetic Counsellor Prevent Ovarian Cancer Program: Systematic identification of high-risk women for ovarian cancer prevention

More information

University of California, San Diego. Colesevelam versus placebo in the treatment of nonalcoholic steatohepatitis

University of California, San Diego. Colesevelam versus placebo in the treatment of nonalcoholic steatohepatitis University of California, San Diego 091491 6 Pages Colesevelam versus placebo in the treatment of nonalcoholic steatohepatitis Collection, Storage, and Use of Blood Samples for Current and Future Genetic

More information

3/6/2017-6/15/2017 Permission to Take Part in a Human Research Study Page 1 of 6

3/6/2017-6/15/2017 Permission to Take Part in a Human Research Study Page 1 of 6 Permission to Take Part in a Human Research Study Page 1 of 6 University at Buffalo Institutional Review Board (UBIRB) Office of Research Compliance Clinical and Translational Research Center Room 5018

More information

VANISH Vasopressin vs Noradrenaline as Initial therapy in Septic shock

VANISH Vasopressin vs Noradrenaline as Initial therapy in Septic shock Investigator: Maurizio Cecconi Patient Information Sheet You are being invited to take part in a research study. Before you decide it is important for you to understand why the research is being done and

More information

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM Gilead Sciences, Inc. GS-US-337-0115, 25-NOV-2013 A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks in Subjects

More information

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM. A5272 Version 2.0, 5/19/11: Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM. A5272 Version 2.0, 5/19/11: Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy A5272 Version 2.0, 5/19/11: Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION Your contacts

More information

Language for Consent Forms

Language for Consent Forms New York University University Committee on Activities Involving Human Subjects 665 Broadway, Suite 804, New York, NY 10012 VOICE: 212-998-4808 FAX: 212-995-4304 www.nyu.edu/ucaihs/ Language for Consent

More information

Subject Name: Sponsor Consent Tmplt Date: Version 2 (17-Jul-2014) Unit Number:

Subject Name: Sponsor Consent Tmplt Date: Version 2 (17-Jul-2014) Unit Number: SCREENING CONSENT TO DETERMINE STUDY ELIGIBILITY AND OPTIONAL RESEARCH AUTHORIZATION TO DONATE ARCHIVED TISSUE SAMPLES FOR MOLECULAR CHARACTERIZATION OF TUMOR YALE UNIVERSITY SCHOOL OF MEDICINE YALE-NEW

More information

Adult Patient Information and Consent Form

Adult Patient Information and Consent Form The ROAM Trial Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial

More information

Research Ethics Board Research Consent Form Genetic Analysis

Research Ethics Board Research Consent Form Genetic Analysis Participant name: DOB: HSC #: Research Ethics Board Research Consent Form Genetic Analysis Title of Research Project: Molecular and Genomic Analysis of Autism Spectrum and Associated Neurodevelopmental

More information

CONSENT FORM TO PARTICIPATE IN A RESEARCH STUDY

CONSENT FORM TO PARTICIPATE IN A RESEARCH STUDY CONSENT FORM TO PARTICIPATE IN A RESEARCH STUDY INVESTIGATOR S NAME: PAMELA S. HINTON PH.D. PROJECT # 1095877 DATE OF PROJECT APPROVAL: SEPTEMBER 12, 2007 STUDY TITLE: EFFICACY OF PLYOMETRICS TO INCREASE

More information

IRB Approved: 09-Jan-2015 To: 08-Jan-2016

IRB Approved: 09-Jan-2015 To: 08-Jan-2016 Developing Assays to Evaluate Immunologic Response to HIV and HIV Vaccines CONSENT FORM/HIPAA AUTHORIZATION FOR VENIPUNCTURE Investigators: Pablo Tebas, MD Phone Number: (215) 349-8092 Study Staff: Joseph

More information

You are the parent or guardian granting permission for a child in this study.

You are the parent or guardian granting permission for a child in this study. Please check one of the following: You are an adult participant in this study. You are the parent or guardian granting permission for a child in this study. Print child s name here: The following information

More information

For Parents and Students: Minor Donor Permit and Information About Donating Blood

For Parents and Students: Minor Donor Permit and Information About Donating Blood DIN NUMBER 102 Chestnut Ridge Road, Montvale NJ 07645 DID For Parents and Students: Minor Donor Permit and Information About Donating Blood Every day people like you need blood: students, teachers, family,

More information

SAMPLE INFORMATION SHEET/CONSENT FORM FOR GENERAL RESEARCH Revised March 2008

SAMPLE INFORMATION SHEET/CONSENT FORM FOR GENERAL RESEARCH Revised March 2008 For use by investigators performing research to be reviewed by the Research Ethics Boards (REBs) of: Hamilton Health Sciences/McMaster University, Faculty of Health Sciences; St. Joseph s Healthcare, Hamilton;

More information

INFORMATION AND CONSENT FORM

INFORMATION AND CONSENT FORM INFORMATION AND CONSENT FORM A RANDOMIZED CONTROLLED TRIAL TO COMPARE THE IMMUNOGENICITY OF SELF- ADMINISTERED AND NURSE-ADMINISTERED INTRADERMAL INFLUENZA VACCINE Investigators Dr. Shelly McNeil Queen

More information

Family & Individual Support Program - Handbook

Family & Individual Support Program - Handbook Family & Individual Support Program - Handbook Welcome to the Simon Fraser Society for Community Living (SFSCL). The SFSCL is an accredited not-for-profit, charitable organization that has been serving

More information

INFORMED CONSENT REQUIREMENTS AND EXAMPLES

INFORMED CONSENT REQUIREMENTS AND EXAMPLES Office of Research Compliance INFORMED CONSENT REQUIREMENTS AND EXAMPLES No investigator may involve a human being as a subject in research unless the investigator has obtained the legally effective informed

More information

Human Subject Institutional Review Board Proposal Form

Human Subject Institutional Review Board Proposal Form FOR IRB USE ONLY Protocol Number: IRB- Human Subject Institutional Review Board Proposal Form Activity Title: PRINCIPAL INVESTIGATOR ASSURANCE I agree to use procedures with respect to safeguarding human

More information

About this consent form

About this consent form Protocol Title: Development of the smoking cessation app Smiling instead of Smoking Principal Investigator: Bettina B. Hoeppner, Ph.D. Site Principal Investigator: n/a Description of Subject Population:

More information

You can save even more lives. Join the British Bone Marrow Registry

You can save even more lives. Join the British Bone Marrow Registry You can save even more lives. Join the British Bone Marrow Registry What is bone marrow? Bone marrow is a remarkable factory. It s the soft, spongy tissue found at the centre of certain bones in your body

More information

Embryo(s) that I/We wish to Donate to Research These are from (check one): Self Donor Code(s):

Embryo(s) that I/We wish to Donate to Research These are from (check one): Self Donor Code(s): SDFC IVF Laboratory Research Consent 11515 El Camino Real, Suite 100 San Diego, CA 92130 Lab phone: (858) 720-3172 Lab fax: (858) 794-6360 lab@sdfertility.com I/We have: Embryo(s) that I/We wish to Donate

More information

Sleep, Wake and Light therapy for depression

Sleep, Wake and Light therapy for depression Sleep, Wake and Light therapy for depression We would like to invite you to take part in a study called Sleep, Wake and Light Therapy for treating depression You do not have to take part if you do not

More information

Barrett s Oesophagus

Barrett s Oesophagus PATIENT INFORMATION Barrett s Oesophagus Radiofrequency Ablation of Barrett s Columnar Lined Oesophagus and Squamous Dysplasia MulticentreTrial with Long Term Follow Up Using a Central Database Project

More information

You are the parent or guardian granting consent for a minor in this study.

You are the parent or guardian granting consent for a minor in this study. Please check one of the following: You are an adult subject in this study. You are the parent or guardian granting consent for a minor in this study. Print minor's name here: The following information

More information

THE KRONGRAD INSTITUTE Sep 25, 2008 WIRB RESEARCH SUBJECT INFORMATION AND CONSENT FORM

THE KRONGRAD INSTITUTE Sep 25, 2008 WIRB RESEARCH SUBJECT INFORMATION AND CONSENT FORM RESEARCH SUBJECT INFORMATION AND CONSENT FORM TITLE: LAPAROSCOPIC PROSTATECTOMY FOR CHRONIC PROSTATITISA Phase II Non-Randomized Clinical Trial PROTOCOL NO.: 1 Protocol #20081635 SPONSOR: INVESTIGATOR:

More information

Your consent to disclosing identifying information

Your consent to disclosing identifying information Your consent to disclosing identifying information HFEA CD form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility

More information

UNIVERSITY OF WASHINGTON MEDICAL CENTER Men s Health Center and Male Fertility Laboratory Sperm & Testis Cryopreservation Program Patient NAME and ID

UNIVERSITY OF WASHINGTON MEDICAL CENTER Men s Health Center and Male Fertility Laboratory Sperm & Testis Cryopreservation Program Patient NAME and ID UNIVERSITY OF WASHINGTON MEDICAL CENTER Men s Health Center and Male Fertility Laboratory Sperm & Testis Cryopreservation Program Patient NAME and ID CONSENT FOR MINOR s SPERM OR TESTIS CRYOPRESERVATION

More information

PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation. Part 1

PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation. Part 1 The Elton John Centre Sussex House 1 Abbey Road Brighton BN2 1ES Tel 01273 523079 Fax 01273 523080 PARTICIPANT INFORMATION SHEET AND CONSENT FORM PrEP Impact Trial: A Pragmatic Health Technology Assessment

More information

Elements of Informed Consent. Lu Pai, Ph.D. Associate Professor, Taipei Medical University IRB member, Tri-service General Hospital

Elements of Informed Consent. Lu Pai, Ph.D. Associate Professor, Taipei Medical University IRB member, Tri-service General Hospital Elements of Informed Consent Lu Pai, Ph.D. Associate Professor, Taipei Medical University IRB member, Tri-service General Hospital Informed Consent Informed consent is process of ensuring that subjects

More information

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH ANONYMOUS DONOR SPERM

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH ANONYMOUS DONOR SPERM THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH ANONYMOUS DONOR SPERM Partner #1 Last Name (Surname): Partner #1 First Name: Partner

More information

CONSENT TO PARTICIPATE IN A RESEARCH STUDY. Why are you being invited to take part in a research study?

CONSENT TO PARTICIPATE IN A RESEARCH STUDY. Why are you being invited to take part in a research study? HRP-502 (6/1/2016) LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER in Shreveport Institutional Review Board (IRB) for the Protection of Human Research Subjects Remove all instructional text and red color-coding

More information

PSYCHOLOGIST-PATIENT SERVICES

PSYCHOLOGIST-PATIENT SERVICES PSYCHOLOGIST-PATIENT SERVICES PSYCHOLOGICAL SERVICES Welcome to my practice. Because you will be putting a good deal of time and energy into therapy, you should choose a psychologist carefully. I strongly

More information

CONSENT TO ACT AS A PARTICIPANT IN A RESEARCH STUDY. University of Pittsburgh

CONSENT TO ACT AS A PARTICIPANT IN A RESEARCH STUDY. University of Pittsburgh University of Pittsburgh Physicians, Department Of Critical Care Medicine Scaife Hall, Sixth Floor 3550 Terrace Street Pittsburgh, PA 15261 T 412-647-3136 F 412-647-8060 CONSENT TO ACT AS A PARTICIPANT

More information

MDCH IRB REVIEW APPLICATION Authority: Code of Federal Regulations Title 45 Part 46

MDCH IRB REVIEW APPLICATION Authority: Code of Federal Regulations Title 45 Part 46 The Michigan Department of Community Health Institutional Review Board for the Protection of Human Research Subjects Capitol View Building, 7 th Floor, 201 Townsend Street, Lansing, MI 48913 Phone: 517/241-1928

More information

by at Study Roles and Responsibilities

by  at Study Roles and Responsibilities Full Study DHA Non-Exempt Human Subject Research Protocol Submission (You may need to click Enable Editing on the yellow bar above in order to complete this template) 1.0 Study Contacts Name/Rank/Degree:

More information

OUTPATIENT SERVICES PSYCHOLOGICAL SERVICES CONTRACT

OUTPATIENT SERVICES PSYCHOLOGICAL SERVICES CONTRACT OUTPATIENT SERVICES PSYCHOLOGICAL SERVICES CONTRACT (This is a detailed document. Please feel free to read at your leisure and discuss with Dr. Gard in subsequent sessions. It is a document to review over

More information

Therapeutic Sperm Banking

Therapeutic Sperm Banking Therapeutic Sperm Banking An Option for Preserving Male Fertility Andrology Laboratory and Reproductive Tissue Bank Information For Patients Men undergoing cancer treatment, including certain types of

More information

Family & Individual Support Program - Handbook

Family & Individual Support Program - Handbook Family & Individual Support Program - Handbook Welcome and Introduction to the Simon Fraser Society for Community Living Welcome to the Simon Fraser Society for Community Living (SFSCL). We have been serving

More information

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM. A Pilot Study for Collection of Anti-Zika Immune Plasma

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM. A Pilot Study for Collection of Anti-Zika Immune Plasma A Pilot Study for Collection of Anti-Zika Immune Plasma CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION Your contacts for this study at the Hospital of the University

More information

FLIPS FreeStyle Libre in Pregnancy Study

FLIPS FreeStyle Libre in Pregnancy Study FLIPS FreeStyle Libre in Pregnancy Study Evaluation of the Accuracy of the FreeStyle Libre Flash Glucose Monitoring System Use in Pregnancy Label Extension Study (CE) Section 1: PARTICIPANT INFORMATION

More information

A study of Standard and New Antiepileptic Drugs SANAD-II

A study of Standard and New Antiepileptic Drugs SANAD-II The SANAD II project is funded by the NIHR Health Technology Assessment Programme. Hospital Logo Address NIHR code A study of Standard and New Antiepileptic Drugs SANAD-II ADULT INFORMATION SHEET www.sanad2.org.uk

More information

RESEARCH INVOLVING HUMAN PARTICIPANTS EXPEDITED/FULL APPLICATION

RESEARCH INVOLVING HUMAN PARTICIPANTS EXPEDITED/FULL APPLICATION This information listed below should be submitted to Florida Tech s IRB if the proposed research has more than minimal risk (none of the exempt conditions apply) or if the research utilizes a special population

More information

Autism Action Network Charter

Autism Action Network Charter Autism Action Network Charter Introduction The Autism Action Network is an exciting opportunity for you to be part of a passionate community committed to helping people with autism to live the life they

More information

A study about how parts of the brain work in people with Down syndrome

A study about how parts of the brain work in people with Down syndrome A study about how parts of the brain work in people with Down syndrome Our names are Carla Startin, Sarah Hamburg and Ros Hithersay. We are researchers working at University College London. We are carrying

More information

Consent and Authorization Document

Consent and Authorization Document Kalani Raphael, MD Page 1 of 14 Consent and Authorization Document BACKGROUND You are being asked to participate in this research study because you have chronic kidney disease, also called CKD, a condition

More information

VERIBEST I.S.D. DETERRENT TO ILLEGAL DRUG AND ALCOHOL USE

VERIBEST I.S.D. DETERRENT TO ILLEGAL DRUG AND ALCOHOL USE VERIBEST I.S.D. DETERRENT TO ILLEGAL DRUG AND ALCOHOL USE 2018-2019 Approved by Veribest ISD Board of Trustees May 15, 2017 The purpose of the drug testing policy is: PURPOSE/OBJECTIVES 1. To prevent illegal

More information

PATIENT INFORMATION SHEET

PATIENT INFORMATION SHEET PATIENT INFORMATION SHEET Optimal management of Rheumatoid Arthritis patients who require Biologic Therapy (ORBIT study) a randomized controlled trial comparing Rituximab and anti-tnf therapy. Invitation

More information

PATIENT INFORMATION SHEET (Sheffield and Southampton Only)

PATIENT INFORMATION SHEET (Sheffield and Southampton Only) PATIENT INFORMATION SHEET (Sheffield and Southampton Only) ENDOMETRIAL SCRATCH TRIAL A Multicentre Randomised Controlled Trial of Induced Endometrial Scratch in Women Undergoing First Time in Vitro Fertilisation

More information

MEMBER SHARE A Pastoral Medical Association - Private Membership Program MEMBER SHARE AGREEMENT (MSA)

MEMBER SHARE A Pastoral Medical Association - Private Membership Program MEMBER SHARE AGREEMENT (MSA) MSA P MEMBER SHARE A Pastoral Medical Association - Private Membership Program MEMBER SHARE AGREEMENT (MSA) I, the undersigned applicant for the value, benefits and mutual promises herein, do hereby apply

More information

Athlete Consent Form:

Athlete Consent Form: Athlete Consent Form: Athlete Name: Prog Ref Code: P I hereby acknowledge that certain risks of injury are inherent to participation in recreational activities, sporting activities and lessons on and associated

More information

Institutional Review Boards and Human Subjects Protection

Institutional Review Boards and Human Subjects Protection Institutional Review Boards and Human Subjects Protection Professor Ron Fricker! Naval Postgraduate School! Monterey, California! 6/25/12 1 Goals for this Lecture! A nasty little bit of history! The Belmont

More information

Research Consent Form for Parents of a non-capable child Genetic Analysis

Research Consent Form for Parents of a non-capable child Genetic Analysis Research Consent Form for Parents of a non-capable child Genetic Analysis Title of Research Project: The SickKids Genome Clinic: Developing and evaluating clinical uses of Whole Genome Sequencing Investigators:

More information

UK Teratology Information Service Regional Drug & Therapeutics Centre Wolfson Unit Newcastle upon Tyne NE2 4HH PARTICIPANT INFORMATION SHEET

UK Teratology Information Service Regional Drug & Therapeutics Centre Wolfson Unit Newcastle upon Tyne NE2 4HH PARTICIPANT INFORMATION SHEET UK Teratology Information Service Regional Drug & Therapeutics Centre Wolfson Unit Newcastle upon Tyne NE2 4HH Tel: 0191 260 6197 Fax: 0191 260 6193 www.uktis.org PARTICIPANT INFORMATION SHEET Influenza

More information

University of Pennsylvania RESEARCH Subject Informed Consent Form AND RESEARCH SUBJECT HIPAA AUTHORIZATION

University of Pennsylvania RESEARCH Subject Informed Consent Form AND RESEARCH SUBJECT HIPAA AUTHORIZATION University of Pennsylvania RESEARCH Subject Informed Consent Form AND RESEARCH SUBJECT HIPAA AUTHORIZATION Protocol Title: Evaluating the impact of cocaine use and HIV infection in arterial wall inflammation

More information

The Johns Hopkins Bloomberg School of Public Health

The Johns Hopkins Bloomberg School of Public Health The Johns Hopkins Bloomberg School of Public Health CONSENT FORM A / NEW RESEARCH PROJECT Title of Research Project: A Randomized Trial of HAART in Acute/Early HIV Infection Version 3.0 Principal Investigator:

More information

revised anatomical gift act

revised anatomical gift act revised anatomical gift act What is an Anatomical Gift? An anatomical gift is a donation of all or part of a human body, after death, for the purpose of transplantation, therapy, research, or education.

More information

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM IRC 002, Version 5.0, 20 AUG 2012: A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational anti-influenza A Immune Plasma for the Treatment of Influenza

More information

INFORMED CONSENT FOR GASTRIC BALLOON INSERTION

INFORMED CONSENT FOR GASTRIC BALLOON INSERTION INFORMED CONSENT FOR GASTRIC BALLOON INSERTION This informed consent document has been prepared to help inform you about the Gastric Balloon Insertion procedure including the risks and benefits, as well

More information

Information Sheet for Stage 1 Screening for parents

Information Sheet for Stage 1 Screening for parents Chief Investigator Prof. Polly Bingley Diabetes & Metabolism Southmead Hospital Bristol BS10 5NB BETA CELL FUNCTION AND ONGOING AUTOIMMUNITY IN LONG STANDING TYPE 1 DIABETES Information Sheet for Stage

More information

Providing for Your Companion Animal s Future Without You

Providing for Your Companion Animal s Future Without You Providing for Your Companion Animal s Future Without You The Humane Society Legislative Fund Since companion animals usually have shorter life spans than their human caregivers, you may have planned for

More information

LETTER OF INFORMATION AND CONSENT FORM

LETTER OF INFORMATION AND CONSENT FORM Page 1 of 7 LETTER OF INFORMATION AND CONSENT FORM Functional neuroimaging of intrinsic hemodynamic networks in bipolar disorder, unipolar depressive disorder, and healthy controls: Finding a biomarker

More information

2010 Sharing Hope Program for men

2010 Sharing Hope Program for men 2010 Sharing Hope Program for men Criteria and Application Made possible by participating sperm banks and fertility centers Program Overview Goal Cancer patients have little opportunity to save for the

More information

Research Consent Form Newton-Wellesley Hospital 2014 Washington Street Newton, MA 02462

Research Consent Form Newton-Wellesley Hospital 2014 Washington Street Newton, MA 02462 Protocol Title: Principal Investigator: Description of Subject Population: Protocol Version: Consent Form Revision Date: ABOUT THIS CONSENT FORM STUDY CONTACTS

More information

Home Sleep Test (HST) Instructions

Home Sleep Test (HST) Instructions Home Sleep Test (HST) Instructions 1. Your physician has ordered an unattended home sleep test (HST) to diagnose or rule out sleep apnea. This test cannot diagnose any other sleep disorders. 2. This device

More information

JDRF Oklahoma. Youth Ambassador Program 2017 Promise Ball 20 th Anniversary. Information Packet

JDRF Oklahoma. Youth Ambassador Program 2017 Promise Ball 20 th Anniversary. Information Packet JDRF Oklahoma Youth Ambassador Program 2017 Promise Ball 20 th Anniversary Information Packet Dear Prospective JDRF Youth Ambassador: I am writing to invite you to participate in the 2017 JDRF Youth Ambassador

More information

NCI Community Oncology Research Program Kansas City (NCORP-KC)

NCI Community Oncology Research Program Kansas City (NCORP-KC) NCI Community Oncology Research Program Kansas City (NCORP-KC) Consent Form Study Title for Study Participants: Comparing Two Dose Levels of Bupropion Versus Placebo for Sexual Desire Official Study Title

More information

IRB policy and procedures 1. Institutional Review Board: Revised Policy and Procedures Elmhurst College

IRB policy and procedures 1. Institutional Review Board: Revised Policy and Procedures Elmhurst College IRB policy and procedures 1 Institutional Review Board: Revised Policy and Procedures Elmhurst College IRB policy and procedures 2 Table of Contents A. Purpose and objectives... p. 3 B. Membership of the

More information

Patient information. Principal Investigator: Prof. Dr. med. Alexander Zarbock

Patient information. Principal Investigator: Prof. Dr. med. Alexander Zarbock Patient information Prospective, randomized, clinical study for analyzing the influence oft he timing of renal replacement therapy on the survival of critically ill patients with acute kidney injury (ELAIN-Trial)

More information

Baa Hózhó Navajo Prep Math Summer Camp 2017

Baa Hózhó Navajo Prep Math Summer Camp 2017 Math Summer Camp 2017 Application Packet Grades 7-12 May 30-June 3, 2017 Navajo Preparatory School, Farmington, NM Residential Camp Application Checklist A complete application must include the following:

More information

Case Number Application page 1. The AIDS Foundation of Western Massachusetts, Inc. P.O. Box 86 Chicopee, MA 01014

Case Number Application page 1. The AIDS Foundation of Western Massachusetts, Inc. P.O. Box 86 Chicopee, MA 01014 Case Number Application page 1 REQUEST FOR SUMMER CAMP FUNDING - 2017 - APPLICATION FORM Name of Child applying for Camp (Last - First -M.I.) Age of Child applying for Camp Name of Parent/Guardian (Last

More information

Genetic Testing Program for Huntington s Disease

Genetic Testing Program for Huntington s Disease Genetic Testing Program for Huntington s Disease Genetic testing for the Huntington s Disease (HD) gene expansion became possible in 1993. This test can be used to confirm the diagnosis in someone who

More information

Eau Claire Tower Fitness Centre MEMBERSHIP APPLICATION

Eau Claire Tower Fitness Centre MEMBERSHIP APPLICATION Eau Claire Tower Fitness Centre MEMBERSHIP APPLICATION SHADED AREAS FOR OFFICE USE ONLY MEMBERSHIP # SECURITY CARD # START DATE DD MM YY NAME: FIRST LAST DATE DD MM YY OF BIRTH HOME ADDRESS HOME/CELL PHONE

More information

Bristol Children s Vaccine Centre

Bristol Children s Vaccine Centre Bristol Children s Vaccine Centre Bristol Children s Vaccine Centre Level 6, UHB Education Centre, Upper Maudlin St., Bristol, BS2 8AE, UK Tel: +44 (0)117 342 0172, Fax: +44 (0)117 342 0209 E-mail: bcvc-study@bristol.ac.uk,

More information

Bloodborne Pathogens. Post-Exposure Incident Packet. An Informational Guide

Bloodborne Pathogens. Post-Exposure Incident Packet. An Informational Guide Bloodborne Pathogens Post-Exposure Incident Packet An Informational Guide Faribault Public Schools Bloodborne Pathogens Post-Exposure Incident Packet This packet has been developed as an informational

More information

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH IDENTIFIED DONOR SPERM

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH IDENTIFIED DONOR SPERM THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH IDENTIFIED DONOR SPERM Partner #1 Last Name (Surname): Partner #1 First Name: Partner

More information